News
-
-
-
PRESS RELEASE
AdJane Reports First Clinical Validation of its OMV Vaccine Platform Inducing Mucosal Immunity in Humans
AdJane reports first clinical validation of its OMV vaccine platform inducing mucosal immunity in humans. Study demonstrates intranasal OMV-based vaccination's ability to trigger systemic and mucosal immune responses -
-
-